- Home
- AVXL vs HIFS Comparison
AVXL vs HIFS Comparison
Compare AVXL & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVXL
- HIFS
- Stock Information
- Founded
- AVXL 2004
- HIFS 1834
- Country
- AVXL United States
- HIFS United States
- Employees
- AVXL N/A
- HIFS N/A
- Industry
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- HIFS Major Banks
- Sector
- AVXL Health Care
- HIFS Finance
- Exchange
- AVXL Nasdaq
- HIFS Nasdaq
- Market Cap
- AVXL 794.0M
- HIFS 581.6M
- IPO Year
- AVXL N/A
- HIFS N/A
- Fundamental
- Price
- AVXL $9.32
- HIFS $259.66
- Analyst Decision
- AVXL Strong Buy
- HIFS
- Analyst Count
- AVXL 2
- HIFS 0
- Target Price
- AVXL $44.00
- HIFS N/A
- AVG Volume (30 Days)
- AVXL 927.5K
- HIFS 91.1K
- Earning Date
- AVXL 08-05-2025
- HIFS 07-11-2025
- Dividend Yield
- AVXL N/A
- HIFS 1.01%
- EPS Growth
- AVXL N/A
- HIFS 14.93
- EPS
- AVXL N/A
- HIFS 12.96
- Revenue
- AVXL N/A
- HIFS $67,590,000.00
- Revenue This Year
- AVXL N/A
- HIFS N/A
- Revenue Next Year
- AVXL N/A
- HIFS N/A
- P/E Ratio
- AVXL N/A
- HIFS $19.16
- Revenue Growth
- AVXL N/A
- HIFS 12.43
- 52 Week Low
- AVXL $4.00
- HIFS $174.39
- 52 Week High
- AVXL $14.44
- HIFS $300.00
- Technical
- Relative Strength Index (RSI)
- AVXL 60.62
- HIFS 58.98
- Support Level
- AVXL $9.09
- HIFS $230.07
- Resistance Level
- AVXL $9.78
- HIFS $250.00
- Average True Range (ATR)
- AVXL 0.41
- HIFS 5.16
- MACD
- AVXL 0.09
- HIFS 3.03
- Stochastic Oscillator
- AVXL 71.58
- HIFS 92.13
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.